RS
Rahul Singhal
About Rahul Singhal
Data last updated:
Rahul Singhal is a Director at Gastomach Pharmaceuticals Private Limited (since 2020) and Whole-Time Director at Endoshine Pharmaceuticals Private Limited (since 2021). The companies operate in Trading, E-Commerce and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹35.8 Lakh; the largest is Gastomach Pharmaceuticals Private Limited at ₹35.6 Lakh (FY 2025). Earlier, Rahul Singhal was a Director at Zeptomus Healthcare Private Limited (2013) and Director at Amnicure Healthcare Private Limited (2013–2016) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Feb 2020 | 2020 | ₹35.6 Lakh (FY 2025) | Active | |
| Whole-Time Director | 07 Jul 2021 | 2021 | ₹22,100 (FY 2022) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 May 2013 | 2013 | ₹8.6 Lakh (FY 2017) | Active | |
| Director | 22 Apr 2013 | 2013 | ₹18,881 (FY 2014) | Strike Off | |
| Director | 08 Sep 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rahul Singhal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Parul Gupta | 10211288 | Gastomach Pharmaceuticals Private Limited | Director |
| Sajal Singhal | 09230580 | Gastomach Pharmaceuticals Private Limited , Endoshine Pharmaceuticals Private Limited | Director |
| Vishal Gupta | 08701399 | Gastomach Pharmaceuticals Private Limited | Director |
| Vikas Chaudhary | 10832747 | Endoshine Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Singhal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Singhal
Rahul Singhal currently holds 2 directorships: Gastomach Pharmaceuticals Private Limited (Director, since 17 Feb 2020, revenue ₹35.6 Lakh (FY 2025)); Endoshine Pharmaceuticals Private Limited (Whole-Time Director, since 07 Jul 2021, revenue ₹22,100 (FY 2022)).
Rahul Singhal was first appointed on 08 Sep 2011 as Director at Tabs And Caps Healthcare Private Limited. The most recent appointment on record is 07 Jul 2021 at Endoshine Pharmaceuticals Private Limited.
The 2 current companies of Rahul Singhal that report revenue have a combined latest revenue of ₹35.8 Lakh: Gastomach Pharmaceuticals Private Limited ₹35.6 Lakh (FY 2025); Endoshine Pharmaceuticals Private Limited ₹22,100 (FY 2022).
Rahul Singhal held 3 earlier board appointments: Zeptomus Healthcare Private Limited (Director, 15 May 2013 to 10 Nov 2013); Amnicure Healthcare Private Limited (Director, 22 Apr 2013 to 20 May 2016); Tabs And Caps Healthcare Private Limited (Director, from 08 Sep 2011).
The current boards of Rahul Singhal's companies include Parul Gupta (Gastomach Pharmaceuticals Private Limited), Sajal Singhal (Gastomach Pharmaceuticals Private Limited), Vishal Gupta (Gastomach Pharmaceuticals Private Limited), Vikas Chaudhary (Endoshine Pharmaceuticals Private Limited).